WO2005082923A1 - 塩基部無保護法による新規核酸合成法 - Google Patents
塩基部無保護法による新規核酸合成法 Download PDFInfo
- Publication number
- WO2005082923A1 WO2005082923A1 PCT/JP2005/003053 JP2005003053W WO2005082923A1 WO 2005082923 A1 WO2005082923 A1 WO 2005082923A1 JP 2005003053 W JP2005003053 W JP 2005003053W WO 2005082923 A1 WO2005082923 A1 WO 2005082923A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- oligomer
- alcohol
- synthesis
- synthesizing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Definitions
- the present invention relates to a novel method for synthesizing a nucleic acid by a base part-free method, particularly to a method for synthesizing a nucleic acid oligomer, which comprises using an alcohol compound as an activator in a phosphoramidite method. .
- Non-Patent Document 1 the H-phosphonate method for performing a hydroxyl-selective condensation reaction using a phosphonium-type condensing agent BOMP is known as a method for synthesizing DNA without protecting the base site! (Non-Patent Document 1).
- This reaction utilizes the fact that the active phosphite intermediate formed during the condensation reaction reacts preferentially with the amino group or hydroxyl group of the base moiety.
- Non-Patent Document 1 Wada.T .; Sato, Y .; Honda, F .; Kawahara, S .; Sekine, M., Journal of the American Chemical Society 1997, 119, 12710—12821.
- Patent Document 2 Gryaznov, S.M .; Letsinger, R.L., Journal of the American Chemical Society 1991, 113, 5876-5877
- Non-Patent Document 2 in which the synthesis of long-chain oligomers is easy, an active phosphite intermediate is formed to form a hydroxyl-selective intermediate.
- a DNA synthesis method that uses such a phosphoric acid ridge, and as a result of intensive research, we completed the present invention.
- the present invention relates to a method for synthesizing a nucleic acid oligomer, which comprises using an alcohol-type activator, preferably a combination of an alcohol-type activator and an acid catalyst in the phosphoramidite method.
- the synthesis was limited by the present invention.
- at least a 10-mer nucleic acid molecule oligomer for example, 20
- the solid-phase method it is possible to synthesize a DNA oligomer of a size similar to that of a solid with extremely high purity. Powerful DNA oligomers can be used advantageously for DNA chips.
- alcohol-type activator refers to a compound capable of forming a highly active phosphite intermediate in the phosphoramidite method, and is an aliphatic hydrocarbon. It does not mean a compound in which a hydrogen atom is replaced by a hydroxyl group.
- any compound known to those skilled in the art can be used. In order to obtain a high condensation efficiency (for example, 95% or more), particularly, hydroxybenzotriazol-1-ol (HOBt ), HOBt derivatives, and compounds in which group power or phenol analog power is also selected.
- HOBt derivatives include those in which 114 substituents such as nitro, bromo, eodo, and trifluoromethyl groups are introduced, for example, 6-trifluoromethylbenzotriazole-1-ol, 6-nitrobenzotriazole- (1) All or (4) 12-trough (6) Trifluoromethylbenzotriazole (1) Preference is given to HOBt derivatives such as ol. Is particularly preferred.
- phenol analog any compound known to those skilled in the art can be used. However, in order to obtain a high condensation efficiency, 2,4-dinitrophenol, 3,4-dicyanphenol and 2 ---- Tro 4 trifluoromethylphenol is preferred.
- any compound known to those skilled in the art can be used as the acid catalyst, but imidazole, tetrazole, and derivatives thereof are particularly preferable.
- these suitable Specific examples include benzimidazole triflate (BIT), 4-ethylthiotetrazole, imidazolimid triflate, and 4,5-dicyanoimidazole.
- the ratio can be appropriately selected by those skilled in the art according to various conditions such as the type of each compound and the reaction solvent.
- the synthesis reaction of the present invention can be carried out in an arbitrary system such as a solid phase or a liquid phase.
- a synthesis method using a solid phase carrier is preferable.
- the solid support any substance known to those skilled in the art, for example, CPG or HCP can be used.
- the nucleic acid is DNA or RNA
- the bases constituting the nucleic acid are those having a cyclonucleoside skeleton at the sugar site in addition to the natural structure, and 2 'and Z or 4' thereof are various types.
- Various modifications and variants such as those having a substituent are also included.
- the phosphoric acid group includes those having a skeleton such as phosphorothioate or methylphosphonate.
- the phosphate protecting group (2-cyanoethyl group) was cleaved with ammonia and deprotected (at room temperature for 12 hours).
- hydroxyl group selectivity is a value generated from the area ratio of the peak of the target compound and the peak of the N-phosphoric acid compound appearing in the HPLC chart.
- trimers were synthesized.
- various dimers were synthesized by using HOBt as the activator in the method of Example 1, and then a condensation reaction was further performed to synthesize various trimers.
- a condensation reaction was further performed to synthesize various trimers.
- significant amounts of by-products were observed when IMT was used.
- Table 1 shows the above results. Table 1 also shows the results when NBT, which is the activator of the proton block method, was used in the CH3CN-NMP mixed solvent system!
- the DNA / RNA Synthesizer 392 of Applied Biosystem Inc. was used for the synthesis.
- the DNA oligomer was synthesized by an automatic synthesizer using an HCP solid phase carrier with a thymidine terminal (1 ⁇ mol, 28 ⁇ mo / g, succinyl linker), and 0.2 M HO tf Bt (6- A mixture of trifluoromethylbenzotriazol-1-ol: alcohol-type activator) and 0.2M BIT (benzimidazole triflate: acid catalyst) in CH CN -N-methyl 2-pyrrolidone (15: 1,
- step operation reagent s time
- the solid phase carrier was washed with 2 2 2 2 mL x 3) and CH CN (1 mL x 3). Finally, the solid phase carrier is
- the product was cut out by treatment with concentrated aqueous ammonia (500 ⁇ L) and deprotected to obtain the desired product.
- a 20-mer DNA fragment is required for an Affymetrix-type DNA chip that is widely used in genetic diagnosis! /, Has a long chain length, and DNA of this length is synthesized without protection of base sites.
- the fact that the technology has become possible has opened the way to the high-throughput preparation of DNA chips with extremely good cost performance, and has a great impact on the biotechnology field.
- the present invention is the first synthetic method that has reached the practical level with the base part non-protection method, and is expected to be applied to gene diagnosis such as SNP analysis of nucleic acid oligomers synthesized by the method of the present invention.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002558581A CA2558581A1 (en) | 2004-03-01 | 2005-02-24 | Novel method for the synthesis of nucleic acid without protecting base moiety |
EP05710654A EP1721908A4 (en) | 2004-03-01 | 2005-02-24 | NEW METHOD FOR SYNTHESIS OF NUCLEIC ACIDS WITHOUT PROTECTION OF THE NUCLEOTIDE BASES |
US10/591,172 US7807821B1 (en) | 2004-03-01 | 2005-02-24 | Method for the synthesis of nucleic acid without protecting base moiety |
JP2006510452A JPWO2005082923A1 (ja) | 2004-03-01 | 2005-02-24 | 塩基部無保護法による新規核酸合成法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004056707 | 2004-03-01 | ||
JP2004-056707 | 2004-03-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005082923A1 true WO2005082923A1 (ja) | 2005-09-09 |
Family
ID=34908936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/003053 WO2005082923A1 (ja) | 2004-03-01 | 2005-02-24 | 塩基部無保護法による新規核酸合成法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US7807821B1 (ja) |
EP (1) | EP1721908A4 (ja) |
JP (1) | JPWO2005082923A1 (ja) |
CA (1) | CA2558581A1 (ja) |
WO (1) | WO2005082923A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014042923A1 (en) | 2012-09-13 | 2014-03-20 | Indiana University Research & Technology Corporation | Compositions and systems for conferring disease resistance in plants and methods of use thereof |
WO2015101515A2 (en) | 2013-12-31 | 2015-07-09 | F. Hoffmann-La Roche Ag | Methods of assessing epigenetic regulation of genome function via dna methylation status and systems and kits therefor |
JP2020132604A (ja) * | 2019-02-25 | 2020-08-31 | 国立大学法人東京工業大学 | 核酸合成用固相担体及びそれを用いた核酸の製造方法 |
WO2021080021A1 (ja) * | 2019-10-24 | 2021-04-29 | 日東電工株式会社 | オリゴヌクレオチドを製造する方法 |
US11905518B2 (en) | 2018-02-12 | 2024-02-20 | Curators Of The University Of Missouri | Small auxin upregulated (SAUR) gene for the improvement of root system architecture, waterlogging tolerance, drought resistance and yield in plants and methods of uses |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008110757A1 (en) * | 2007-03-09 | 2008-09-18 | Ge Healthcare Limited | Separation process |
JP5438922B2 (ja) * | 2008-06-25 | 2014-03-12 | 日東電工株式会社 | 核酸の製造方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6251695A (ja) * | 1985-08-29 | 1987-03-06 | Yuki Gosei Yakuhin Kogyo Kk | ホスホロアミダイト類の合成法 |
JPH1180185A (ja) * | 1997-09-05 | 1999-03-26 | Res Dev Corp Of Japan | オリゴヌクレオチドの化学合成法 |
JP2003002895A (ja) * | 2001-05-30 | 2003-01-08 | Tokyo Inst Of Technol | 核酸の合成法 |
JP2003028871A (ja) * | 1999-12-06 | 2003-01-29 | Fuji Photo Film Co Ltd | 反応性固相担体及びdna断片検出用具 |
JP2004099532A (ja) * | 2002-09-10 | 2004-04-02 | Sigma Genosys Japan Kk | オリゴヌクレオチド合成法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1106603A3 (en) | 1999-12-06 | 2003-11-19 | Fuji Photo Film Co., Ltd. | DNA chip and reactive solid carrier |
US20030096257A1 (en) | 1999-12-06 | 2003-05-22 | Hiroshi Shinoki | DNA chip and reactive solid carrier |
-
2005
- 2005-02-24 JP JP2006510452A patent/JPWO2005082923A1/ja active Pending
- 2005-02-24 US US10/591,172 patent/US7807821B1/en not_active Expired - Fee Related
- 2005-02-24 WO PCT/JP2005/003053 patent/WO2005082923A1/ja active Application Filing
- 2005-02-24 EP EP05710654A patent/EP1721908A4/en not_active Withdrawn
- 2005-02-24 CA CA002558581A patent/CA2558581A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6251695A (ja) * | 1985-08-29 | 1987-03-06 | Yuki Gosei Yakuhin Kogyo Kk | ホスホロアミダイト類の合成法 |
JPH1180185A (ja) * | 1997-09-05 | 1999-03-26 | Res Dev Corp Of Japan | オリゴヌクレオチドの化学合成法 |
JP2003028871A (ja) * | 1999-12-06 | 2003-01-29 | Fuji Photo Film Co Ltd | 反応性固相担体及びdna断片検出用具 |
JP2003002895A (ja) * | 2001-05-30 | 2003-01-08 | Tokyo Inst Of Technol | 核酸の合成法 |
JP2004099532A (ja) * | 2002-09-10 | 2004-04-02 | Sigma Genosys Japan Kk | オリゴヌクレオチド合成法 |
Non-Patent Citations (3)
Title |
---|
DABKOWSKI W. ET AL.: "2,4-dinitrophenol: a novel activating reagent in nucleotide synthesis via the phosphoramidite route.", TETRAHEDRON LETTERS., vol. 41, no. 39, 2000, pages 7535 - 7539, XP004217345 * |
OHKUBO A. ET AL.: "A new strategy for the synthesis of oligodeoxynucleotides directed towards perfect O selective internucleotidic bond formation without base protection.", TETRAHEDRON LETTERS., vol. 45, no. 2, 2004, pages 363 - 366, XP004478904 * |
See also references of EP1721908A4 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014042923A1 (en) | 2012-09-13 | 2014-03-20 | Indiana University Research & Technology Corporation | Compositions and systems for conferring disease resistance in plants and methods of use thereof |
US9816102B2 (en) | 2012-09-13 | 2017-11-14 | Indiana University Research And Technology Corporation | Compositions and systems for conferring disease resistance in plants and methods of use thereof |
WO2015101515A2 (en) | 2013-12-31 | 2015-07-09 | F. Hoffmann-La Roche Ag | Methods of assessing epigenetic regulation of genome function via dna methylation status and systems and kits therefor |
US11905518B2 (en) | 2018-02-12 | 2024-02-20 | Curators Of The University Of Missouri | Small auxin upregulated (SAUR) gene for the improvement of root system architecture, waterlogging tolerance, drought resistance and yield in plants and methods of uses |
JP2020132604A (ja) * | 2019-02-25 | 2020-08-31 | 国立大学法人東京工業大学 | 核酸合成用固相担体及びそれを用いた核酸の製造方法 |
JP7298866B2 (ja) | 2019-02-25 | 2023-06-27 | 国立大学法人東京工業大学 | 核酸合成用固相担体及びそれを用いた核酸の製造方法 |
WO2021080021A1 (ja) * | 2019-10-24 | 2021-04-29 | 日東電工株式会社 | オリゴヌクレオチドを製造する方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2558581A1 (en) | 2005-09-09 |
EP1721908A4 (en) | 2009-12-16 |
EP1721908A1 (en) | 2006-11-15 |
US7807821B1 (en) | 2010-10-05 |
JPWO2005082923A1 (ja) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sproat et al. | Highly efficient chemical synthesis of 2′-O-methyloligoribonucleotides and tetrabiotinylated derivatives; novel probes that are resistant to degradation by RNA or DNA specific nucleases | |
EP1954671B1 (en) | Polynucleotide labelling reagent | |
US5510476A (en) | Carbocation scavenging during oligonucleotide synthesis | |
JP2899111B2 (ja) | オリゴヌクレオチドの5’末端へ官能基を提供するための修飾された亜リン酸中間体 | |
WO2005082923A1 (ja) | 塩基部無保護法による新規核酸合成法 | |
Qiu et al. | Solid phase click ligation for the synthesis of very long oligonucleotides | |
JPH11501936A (ja) | 光除去可能な保護基を用いた核酸合成 | |
JPH035495A (ja) | 修飾された核酸を製造するための修飾されたホスホルアミダイト法 | |
JP2002517404A (ja) | オリゴヌクレオチド合成のためのアクチベーター | |
JP7075680B2 (ja) | オリゴヌクレオチド合成用セグメントおよびその製造方法、ならびにそれを用いたオリゴヌクレオチドの合成方法 | |
JPH06509542A (ja) | オリゴマーを合成するための改良法 | |
Thuong et al. | Solid phase synthesis of oligo-α-and oligo-β-deoxynucleotidescovalently linked to an acridine | |
JPH1180185A (ja) | オリゴヌクレオチドの化学合成法 | |
WO2001016151A1 (fr) | Acide nucleique a photocouplage reversible et phosphoroamidite | |
WO2008141799A1 (en) | Oligophosphoramidates | |
AU2006316903B8 (en) | Polynucleotide labelling reagent | |
AU2006221999A1 (en) | Synthesis of oligonucleotides | |
US20030129593A1 (en) | Process for producing multiple oligonucleotides on a solid support | |
WO2005080404A1 (ja) | 核酸固相合成用シリルリンカー | |
US20030105056A1 (en) | Protected linker compounds | |
Suchsland et al. | Synthesis of fully protected trinucleotide building blocks on a disulphide-linked soluble support | |
JPS5993099A (ja) | オリゴヌクレオチド誘導体およびその製造法 | |
JP2003002895A (ja) | 核酸の合成法 | |
AU2005315631A1 (en) | Synthesis of phosphitylated compounds using a quaternary heterocyclic activator | |
JPS6363695A (ja) | ヌクレオシドホスホロチオイツトを用いたオリゴヌクレオチドの固相合成法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006510452 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2558581 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005710654 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2005710654 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10591172 Country of ref document: US |